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IN T R O D U C T IO N
Proteoglycans (PGs) are macromolecules with a ubiquitous tissue distribution. They each contain a core protein with one or more covalently bound glycosaminoglycan (GAG) si de-chains,1,2 The amino acid sequences of many PG core proteins have been obtained by cloning of their corresponding cDNAs.3 Some of these PGs, such as perlecan,4 syndecan-1,5 and epican (a member of the CD44 family),6 contain heparan sulphate (HS) side-chains. These heparan sulphate proteoglycans (HSPGs) are found both on cell surfaces and in basal membranes (BMs), where they function as a structural element and are involved in regulatory functions. BM-associated PGs contribute to the charge-dependent permeability of BMs, especially in the glomerular BM.7, 8 Several studies indicate that BM HSPGs are capable of binding a wide variety of bio logically active proteins including growth factors such as basic growth factor (bFGF).() Interaction of BM HSPGs with other BM components such as (ibroncctin, laminin, and collagen type IV accounts for their role in the assembly and integrity of the BM,1(U)
Increasing amounts of data have become available on the localization and function of HSPGs in stratified epithelia. Most studies, however, describe only the presence of celi-surface HSPGs. Syndecan-1 is, for example, localized over the entire surface of keratinocytes, especially in the suprabasal layers, whereas the basal layer shows modest expression.5 Antibodies that recognize the core proteins of CD4412 and biglycan13 bind to the intercellular space of the entire epidermis.
At present, few data are available on the localization and function of BM HSPGs in human skin. We have previously investigated the presence of BM HSPGs in normal human skin and in epidermal tumours, showing that HSPGs are associated with the basal membranes of the epithelia and dermal capillaries.14 Murdoch et a!}5 also found strong immunoreactivity for perlecan at the dermal/epidermal junction of normal human skin. A faint reaction was observed in fibrous strands leading into the underlying dermis, the upper dermis, and the perivascular region. The keratinocytes were consistently negative. Recently we described the immunoreactivity of H SPG s during the first 2 weeks of wound healing in norm al human skin.16 Using an antibody directed against the HS side-chain and comparing it with the BM component laminin, we observed a disparity in the time o f reappearance during restoration of the BM. Consid ering the variety of functions attributed to BM HSPGs, it is likely that the expression levels and the quality of HSPGs could affect several aspects of wound healing, such as re-epithelialization, epidermal growth control, a n d the physiochemical properties of the BM, such as its permeability and selectivity for macromolecules.
In the present investigation, we studied regeneration o f the BM following partial thickness wounding of norm al human skin, during a 1-year period, using a panel of recently developed monoclonal antibodies (MAbs) against the HSPG core protein, against different epitopes within the HS side-chains, and against laminin (LN). The results indicate that there are distinct kinetics with respect to the reappearance of HSPG epitopes, A highly sulphated epitope of HS remains absent up to 2 months after wounding, while a low sulphated epitope reappears after 7 days. The relationship with epidermal proliferation and BM permeability, and the putative functional implications are discussed,
MATERIALS AND METHODS

Antibodies
MAbs directed against the HSPG core protein (JM-72) and the heparan sulphate side-chain (JM-403 and JM-13) were developed as previously described (Table I) .17~19 MAb JM-72 is directed against the core protein of HSPG from human glomerular BM. Analysis of the immunofluorescence pattern of MAb JM-7217 and the amino acid composition of the core protein20 recognized by JM-72 suggests glomerular BM HSPG to be related to agrin, rather than to perlecan.21"23 Anti-HS MAb JM-1319 reacts with an HS epitope containing O-sulphates. This is based on the unpublished obser vation that MAb JM-13 does not bind to the nonsulphated Escherichia coli K5 capsular polysaccharide, which has the same basic structure as the unmodified biosynthetic precursor of heparin/HS, but strongly binds to chemically O-sulphated K5. This latter K5 derivative contains an average of 1*2 O-sulphate (but not N-sulphate) groups per disaccharide unit. The location of the O-sulphates would presumably primarily involve C-6 of the glucosamine unit, along with C-2 and/or C-3 of the glucuronic acid units. The epitope fine specificity of anti-HS MAb JM-403 has been published18 and involves an N-unsubstituted glucosamine unit along with an N-sulphated glucosamine unit. Iduronate residues and O-sulphates interfere strongly with anti body binding. The epitope is exclusively found in low sulphated (<1 sulphate per disaccharide unit) HS isoforms.
A MAb directed against laminin and a polyclonal Ab directed against human fibrin/fibrinogen were obtained from DAKO Corporation (Carpintería, U.S.A.). A MAb to human Ki-67 antigen (MIB-1 clone) was obtained from Immunotech S.A, (Marseille, France). Rabbit anti-mouse immunoglobulins conjugated with horseradish peroxidase (RAMPO) and swine anti rabbit immunoglobulins conjugated with horseradish peroxidase (SWARPO) were obtained from DAKO Corporation (Carpintería, U.S.A.).
Tissues
To study wound healing in normal human skin, the following model was applied to healthy volunteers (eight subjects aged 25-55 years, mean 42 years). At day 0, in each subject, four wounds were made under local anaesthesia on the outside of the upper arm using a biopsy punch of 3 mm diameter. The wound depth was approximately 1 mm. At days 1, 2, 4, 7, 14, 60, and 365 after wounding, punch biopsies of 4 mm diameter were taken comprising the previously made wounds and some surrounding tissue. The wound depth was approxi mately 5 mm. Three to four biopsies were studied per time point. Permission from the local medical-ethical committee was obtained prior to the experiment.
Immunohistology
Each biopsy was snap-frozen in liquid nitrogen and stored at -80°C until further use. Cryosections were prepared tising standard procedures. Sections were incubated with MAbs JM-72, JM-403, JM-13, MIB-1, and anti-laminin as described previously.14117 After incubation with RAMPO or SWARPO, the sections were developed with aminoethyl carbazole as the chromogenic substrate. All sections were counterstained with haematoxylin.
Scoring o f the sections
BM staining was classified as continuous (+) or patchy ( ± ) (see Table II ). No attempt was made to quantify staining intensity. Ki-67 staining was quantified by counting the number of moderately and strongly positive basal and suprabasal nuclei per unit of 100 basal cells. unimpaired wound healing. A dense infiltrate of inflam matory cells was present shortly after injury, and the wound bed was filled with fibrinous material. Within 2 days after wounding, re-epithelialization had started and a sheet of ingrowing keratinocytes was visible. Up to 4 days after injury, polymorphonuclear leuko cytes were prominently present. After 1 week, reepithelialization was complete in nearly all wounds and only a few scattered polymorphonuclear leukocytes re mained in the original wound bed. After 2 weeks, the keratinocytes had resumed their normal stratification. However, the epidermis still remained acanthotic and rete ridges were lacking. In the dermis, granulation tissue with mononuclear cells, fibroblasts, and endothelial cells was present. Up to 1 year after wounding the wound area could still be distinguished from the surrounding tissue by the absence of epidermal rete ridges, dermal fibroplasia, and the absence of elastic fibres.
RESULTS
Histopathology o f the wounds
hnmunolocalization o f BM components during wound healing
Figures 1 and 2 show the time course of expression of BM components after partial thickness wounding. Intact human skin gives identical continuous» linear staining of the dermo-epidermal BM and the BM of dermal vascu lature for three MAbs against different HSPG epitopes (JM-403: low-sulphated HS; JM-13: high-sulphated HS; JM-72: core protein) and for an anti-laminin MAb (see Figs 1A and 2A: staining patterns with JM-403 and laminin MAbs are not shown). After wounding of the skin, no marked changes were noted in the staining patterns for any of the antibodies in the BM of the normal skin at the wound margins during the time course studied. During the re-epithelialization process (which starts within 2 days), the BM zone of the neo-epidermis was negative for all HSPG antibodies and the laminin antibody up to day 4 (Figs IB and 2B). One week after wounding, when re-epithelialization is com plete, weak linear staining with the JM-72, JM-403, and anti-laminin antibodies was seen in the BM zone of the neo-epidermis (not shown). Staining for JM-13 remained negative (not shown). From day 7 up to 1 year after wounding, staining for JM-72, JM-403, and antilaminin was increased to normal intensities (Figs 2C and 2D) . Remarkably, the JM-13 antibody, which recognizes a high-sulphated epitope of the HS side-chain, remained undetectable up to 2 months after wounding, indicating that in spite of the intact epidermis and nearly normal morphology, the BM is not completely restored ( shows absent staining after 14 days). Biopsies taken after 1 year revealed a staining pattern of JM-13 which was similar to that of normal skin (Fig. ID) . Table II summarizes the immunohistochemical data.
Epidermal hyperproliferation and BM permeability during wound healing
The structural integrity of the BM, and the presence of HSPGs in particular, could affect several properties of the neo-epidermis, taking into account the putative functions of HSPGs. To investigate whether the absence of high-sulphated HS epitopes correlated with growth alterations of the epidermis, we performed an immuno histochemical staining for the Ki-67 antigen, which is expressed by cycling cells. In a previous study24 we quantified the number of Ki-67-positive cells during normal wound healing from day 0 to day 14. Here we extended our observations lip to i year. We found that the epidermis remained hyperproliferative up to 2 months after injury. In normal skin we found \4 ± 2 Ki-67-positive cells per unit BM, which were present both in the basal layer and in the first suprabasal layer (Fig. 3A) . These cells probably represent the stem cells and the transit amplifying cell population. As shown before,24 the cycling population was dramatically increased in the neo-epidermis after wound closure at days 7 and 14. Here we found in addition that after 2 months the epidermis was still hyperproliferative (66 ± 45 positive cells per unit BM, see Fig. 3B ). After 1 year, the number of Ki-67-positive cells in the epi dermis overlying the former wound bed was normalized (16 ± 1 positive cells per unit BM, see Fig. 3C ).
Previous studies have suggested that the negative charge of the basal membrane which is provided by the HS molecules is responsible for the selectivity and permeability of the glomerular BM.7'8 The BM of normal intact skin is thought to be relatively im permeable to high molecular weight plasma proteins.25 Here we used an anti-fibrin antiserum to detect fibrino gen in the epidermis, as a measure for changes in BM permeability during wound healing. Figure 4A shows that normal epidermis is virtually negative for fibrino gen, whereas the connective tissue shows positive stain ing. Obviously, in the early stages of wound healing, the wound bed is strongly positive for fibrinogen/fibrin (not shown). At day 14 after wound closure, we observed strong pericellular staining for fibrinogen in the epi dermis (Fig. 4B) . After 2 months, strong epidermal staining for fibrinogen was still observed in two biopsies JOURNAL OF p a t h o l o g y , v o l . 183: 2 6 4 -2 7 1 (1 9 9 7 ) ........ 
